证券代码：920050 证券简称：爱舍伦 公告编号：2026-016 江苏爱舍伦医疗科技集团股份有限公司 关于签署募集资金四方监管协议的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误 导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带法 律责任。 一、募集资金基本情况 江苏爱舍伦医疗科技集团股份有限公司（以下简称"公司 "）向不特定合格投 资者公开发行股票并在北京证券交易所上市申请于2025年10月24日经北京证券交易 所上市委员会审核同意，并于2025年12月10日获得中国证券监督管理委员会（以下 简称" 中国证监会 "）出具的《关于同意江苏爱舍伦医疗科技集团股份有限公司 向不特定合格投资者公开发行股票注册的批复》（证监许可〔2025〕2754号），公 司股票于2026年1月21日在北京证券交易所上市。 公司本次向不特定合格投资者公开发行普通股 16,919,834股，每股面值为人民 币1.00元，每股发行价格为15.98元，募集资金总额为人民币270,378,947.32元，扣 除发行费用人民币（不含税）30,202,199.50元，公司本次募集资金净额为 ...

证券代码：920050 证券简称：爱舍伦 公告编号：2026-019 （三）会议召开的合法合规性 江苏爱舍伦医疗科技集团股份有限公司 关于召开 2026 年第一次临时股东会通知公告（提供网络投票） 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开基本情况 （一）股东会届次 本次会议为 2026 年第一次临时股东会。 （二）召集人 本次股东会的召集人为董事会。 根据《公司法》和《公司章程》的有关规定，公司董事会于 2026 年 2 月 9 日召开第二届董事会第十八次会议，审议通过了《关于提请召开公司 2026 年第 一次临时股东会的议案》，表决结果为同意 7 票，反对 0 票，弃权 0 票。 本次股东会的召集和召开程序符合《中华人民共和国公司法》等有关法律、 法规及《公司章程》的有关规定。 （四）会议召开方式 本次会议采用现场投票和网络投票相结合方式召开。 公司同一股东只能选择现场投票、网络投票中的一种方式，同一表决权出 现重复表决的，以第一次投票结果为准。 （五）会议召开日期和时间 1、现场 ...

证券代码：920050 证券简称：爱舍伦 公告编号：2026-012 江苏爱舍伦医疗科技集团股份有限公司 第二届董事会第十八次会议决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 （一）会议召开情况 1.会议召开时间：2026 年 2 月 9 日 2.会议召开地点：公司会议室 3.会议召开方式：现场与通讯结合 4.发出董事会会议通知的时间和方式：2026 年 2 月 3 日以通讯方式发出 5.会议主持人：董事长张勇先生 6.会议列席人员：公司高级管理人员 7.召开情况合法合规的说明： 本次会议召集、召开程序符合《公司法》和《公司章程》的有关规定，会议 召开合法有效。 （二）会议出席情况 会议应出席董事 7 人，出席和授权出席董事 7 人。 董事张利芳、朱燕萍、宋频然、孙宏涛因工作原因以通讯方式参与表决。 （二）审议通过《关于调整募集资金投资项目拟投入募集资金金额的议案》 二、议案审议情况 （一）审议通过《关于变更公司注册资本、公司类型及修订<公司章程>的议案》 1.议案内 ...

Investment Rating - The report maintains an "Outperform" rating for the industry [5] Core Insights - The North Exchange's stock market activity has significantly increased, with new stock market funds exceeding 1 trillion [1] - The North Exchange added 5 new listed companies this month, bringing the total to 292, with a total market value of 936.30 billion and a circulating market value of 580.36 billion, reflecting increases of 7.7% and 10.3% respectively [1][13] - The North Exchange's trading volume and amount for the month were 24.52 billion shares and 607.72 billion, with a month-on-month increase of 26.8% in volume and 38.6% in amount [1][16] - The North Exchange 50 Index had a price-to-earnings ratio (PE-TTM) of 45.96, ranking in the 60.46th percentile over the past two years, and a price-to-book ratio (PB-MRQ) of 9.50, ranking in the 91.10th percentile [2][25] - The North Exchange's various sectors, except for the automotive sector, experienced a general increase in returns this month, with significant gains in media, non-ferrous metals, telecommunications, public utilities, and agriculture [32][37] Summary by Sections Market Overview - The North Exchange's trading activity has shown a notable increase, with a monthly trading volume of 24.52 billion shares and a trading amount of 607.72 billion, marking a month-on-month increase of 26.8% and 38.6% respectively [1][16] - The North Exchange's total market value reached 936.30 billion, with a circulating market value of 580.36 billion, reflecting increases of 7.7% and 10.3% respectively [1][13] Valuation - As of January 30, the North Exchange 50 Index's PE-TTM was 45.96, and its PB-MRQ was 9.50, indicating high valuation levels compared to historical data [2][25] - The dividend yield was recorded at 0.72, placing it in the 18.09th percentile over the past two years [2][25] Industry Performance - The North Exchange 50 Index experienced a monthly increase of 6.33%, while the specialized index rose by 6.06% [32] - Most sectors saw positive returns, with notable increases in media, non-ferrous metals, telecommunications, public utilities, and agriculture [37] - The top-performing stocks this month included Kema Materials, Medela, Aishalon, and Guoliang New Materials [42]

Investment Rating - The report maintains an "Outperform" rating for the industry [5] Core Insights - The Beijing Stock Exchange (BSE) has seen a significant increase in trading activity, with a notable rise in both transaction volume and value [1][20] - The total number of listed companies on the BSE reached 292, with a total market capitalization of 936.30 billion and a circulating market value of 58.04 billion, reflecting increases of 7.7% and 10.3% respectively [1][13] - The BSE's new stock market has attracted over 1 trillion in frozen funds, indicating strong market interest [3] Market Overview - In January 2026, the BSE's trading volume was 24.52 billion shares, with a transaction value of 607.72 billion, marking a month-on-month increase of 26.8% in volume and 38.6% in value [1][16] - The average daily margin financing balance increased to 8.83 billion, up 14.1% from the previous month [23] Valuation Metrics - As of January 30, the PE ratio of the BSE 50 Index was 45.96, placing it at the 60.46th percentile over the past two years, while the PB ratio was 9.50, at the 91.10th percentile [25][26] - The dividend yield stood at 0.72, at the 18.09th percentile over the same period [25] Industry Performance - The BSE 50 Index experienced a monthly increase of 6.33%, while the specialized index rose by 6.06% [32] - Most sectors, except for the automotive industry, saw positive returns, with significant gains in media, non-ferrous metals, telecommunications, public utilities, and agriculture [37][42] New Listings - Five new companies were listed on the BSE this month, including Meidele (920119.BJ), Nongda Technology (920159.BJ), Guoliang New Materials (920076.BJ), Aishalen (920050.BJ), and Kema Materials (920086.BJ) [1][3][13] Policy and Events - The BSE is characterized by a dual approach of "strict regulation" and "promoting activity," as evidenced by the recent delisting of ST Guandao and the strong market appeal indicated by the frozen funds exceeding 1 trillion [3]

Financing & Review - In January 2026, the Beijing Stock Exchange (BSE) issued 5 new stocks, raising a total of 1.779 billion yuan[5] - The average review cycle for companies was 251 days, with 10 companies passing the review, a decrease of 3 from the previous month[5] - As of January 2026, there are 24 companies that have passed the review but have not yet registered, aiming to raise 8.127 billion yuan[5] Subscription & Issuance - The median first-day price increase for the 5 new stocks listed in January was +186.93%, with individual increases of +367.92%, +204.40%, +186.93%, +178.00%, and +105.63%[3] - The cumulative subscription yield for new stocks in January 2026 was +0.42%, while the cumulative yield for 2025 was +3.31%[3] - The average maximum subscription amount for new stocks in January was 16.01 million yuan, with a median freezing fund range of 828.08 billion to 1,058.86 billion yuan[5] Market Trends & Predictions - The BSE is entering a phase of accelerated expansion, with a neutral expectation of 40 new stock issuances in 2026, potentially raising a total of 11.625 billion yuan[5] - The expected first-day price increase for directly priced new stocks is projected at 300%, with various scenarios considered[5] - The anticipated online subscription yield for maximum subscriptions is estimated at 366,100 yuan, with varying yields based on different investment amounts[5] Investment Analysis - Investors are encouraged to actively monitor new stock subscription opportunities on the BSE, as the increase in issuance volume is expected to offset concerns about reduced first-day premiums[5] - The report highlights the potential for significant returns from inquiry-based issuances, particularly for high-profile companies currently under review[5] - Risks include slower-than-expected issuance rates and potential changes in the BSE's new stock issuance system[5]

Summary of Key Points Core Viewpoint - In January 2026, a total of 9 new companies were listed on the Shanghai Stock Exchange, Shenzhen Stock Exchange, and Beijing Stock Exchange, raising a total of 9.053 billion yuan [1]. Group 1: Listing Overview - The new listings included 3 companies on the main boards of Shanghai and Shenzhen, 1 on the Sci-Tech Innovation Board, and 5 on the Beijing Stock Exchange [1]. - The listed companies are distributed across 8 provinces and municipalities, with Zhejiang having 2 companies, and Liaoning, Guangdong, Shandong, Hebei, Jiangsu, Chongqing, and Shaanxi each having 1 company [1]. Group 2: Fundraising by Company - The top five companies by fundraising amount are: - Zhenstone Co., Ltd. (振石股份) raised 2.919 billion yuan, located in Zhejiang [1]. - Hengyun Chang (恒运昌) raised 1.561 billion yuan, located in Guangdong [2]. - Shaanxi Tourism (陕西旅游) raised 1.555 billion yuan, located in Shaanxi [7]. - Zhixin Co., Ltd. (至信股份) raised 1.240 billion yuan, located in Chongqing [6]. - Meidel (美德乐) raised 670 million yuan, located in Liaoning [2]. Group 3: Detailed Company Listings - Detailed listings include: - Zhenstone Co., Ltd. (振石股份) on the main board, raised 2.919 billion yuan on January 29, 2026 [8]. - Hengyun Chang (恒运昌) on the Sci-Tech Innovation Board, raised 1.561 billion yuan on January 28, 2026 [8]. - Meidel (美德乐) on the Beijing Stock Exchange, raised 670 million yuan on January 30, 2026 [8]. - Nongda Technology (农大科技) on the Beijing Stock Exchange, raised 400 million yuan on January 28, 2026 [3]. - Guoliang New Materials (国亮新材) on the Beijing Stock Exchange, raised 194 million yuan on January 22, 2026 [4]. - Aisheren (爱舍伦) on the Beijing Stock Exchange, raised 270 million yuan on January 21, 2026 [5]. - Kema Materials (科马材料) on the Beijing Stock Exchange, raised 243.93 million yuan on January 16, 2026 [8]. - Zhixin Co., Ltd. (至信股份) on the main board, raised 1.240 billion yuan on January 15, 2026 [6]. - Shaanxi Tourism (陕西旅游) on the main board, raised 1.555 billion yuan on January 6, 2026 [7].

证券代码：920050 证券简称：爱舍伦 公告编号：2026-011 江苏爱舍伦医疗科技集团股份有限公司 关于签署募集资金三方监管协议的公告 二、募集资金监管协议的签署情况 为规范公司募集资金管理，保护投资者权益，根据《北京证券交易所股票上市 规则》和《北京证券交易所上市公司持续监管指引第9号——募集资金管理》等相关 法律、法规和规范性文件的规定，公司（甲方）开设募集资金专项账户存放本次向 不特定合格投资者公开发行股票的募集资金，并已分别与存放募集资金的商业银行 （乙方）和东吴证券股份有限公司（丙方）签订《募集资金专户三方监管协议》（ 以下简称"三方监管协议 "）。 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误 导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带法 律责任。 一、募集资金基本情况 江苏爱舍伦医疗科技集团股份有限公司（以下简称"公司 "）向不特定合格投 资者公开发行股票并在北京证券交易所上市申请于2025年10月24日经北京证券交易 所上市委员会审核同意，并于2025年12月10日获得中国证券监督管理委员会（以下 简称" 中国证监会 "）出具的《关于 ...

Core Insights - The report indicates that since the fourth quarter, the funding structure of the Beijing Stock Exchange (BSE) has shown a "dual expansion" characteristic, with both the number and attention towards index funds steadily increasing, forming a preliminary bottom position for index products. Concurrently, some active funds are beginning to identify individual stocks with growth potential and undervaluation advantages, transitioning from a concentrated to a structured optimization approach, maintaining overall market stability [7][16] - From the market ecology perspective, the concentration of index constituent stocks has increased, and the valuation anchoring effect is gradually becoming evident. Some newly listed stocks with solid fundamentals and low coverage have become focal points for new incremental funds. As the allocation logic evolves towards the medium to long term, the market style is gradually shifting to a "selected + low turnover" characteristic. Overall, the current valuation of the BSE market offers relative cost-effectiveness, with a resonance structure among index funds, active funds, and new stock supply, which is expected to provide medium-term support for the market [7][16] Market Review and Valuation - As of January 29, 2026, the BSE 50 Index rose by 6.64% in January, with a maximum increase of 3.96% during the period. Among BSE stocks, 222 stocks increased, 69 stocks decreased, and none remained flat [8][17] - The average PE (TTM) of the BSE 50 Index as of January 29, 2026, is 64.50 times, with a median of 64.74 times. In comparison, the average PE (TTM) of the ChiNext Index is 43.24 times, and the Sci-Tech Innovation Board is 175.49 times [22] New Stock Dynamics - In January, four new stocks were listed on the BSE, bringing the total number of listed companies to 291 as of January 29, 2026. From January 1 to January 30, 2026, five companies were subscribed and five were listed [32] Key Company Announcements - The report includes various company announcements, highlighting significant contracts and operational updates from companies such as Copper Crown Mining, Taihu Yuanda, and Dana Biotechnology, which indicate ongoing business activities and strategic developments [40]

【导读】下周2只新股可申购，恒运昌是半导体设备核心零部件供应商 中国基金报记者 闻言 A股打新投资者注意啦！ 根据目前发行安排，下周有2只新股可申购，分别是北交所新股爱舍伦、上交所科创板新股恒运昌，具 体申购时间分别是1月12日、1月16日。 爱舍伦是医用敷料领域头部企业 爱舍伦的申购代码是920050，发行价为15.98元/股，发行市盈率为14.99倍，参考行业市盈率为29.79 倍。 爱舍伦此次总发行数量为1692万股，网上发行数量为1523万股。投资者参与网上申购爱舍伦，申购数量 上限为76.13万股。 爱舍伦作为一家医用敷料生产商，主要从事应用在专业康复护理与医疗防护领域的一次性医用耗材研 发、生产和销售，通过ODM（原始设计制造商）/OEM（原始设备制造商）等方式为国际知名医疗器械 品牌厂商提供相关产品。 近年来，爱舍伦的重要客户包含Medline集团、Zarys International Group、Sejong Healthcare Co., Ltd.、苏 州鼎康进出口有限公司、San Pablo Commercial Corp.等。 2022年至2024年及2025年上半年，爱舍伦的营业收入 ...